# CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

> **NCT00847912** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 954 (actual)

## Conditions studied

- Carcinoma, Basal Cell
- Carcinoma, Squamous Cell
- Skin Neoplasms
- Skin Diseases
- Neoplasms, Basal Cell
- Neoplasms, Squamous Cell
- Carcinoma

## Interventions

- **DRUG:** 5-fluorouracil
- **DRUG:** Placebo, vehicle control

## Key facts

- **NCT ID:** NCT00847912
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-26
- **Primary completion:** 2013-06-28
- **Final completion:** 2016-07-30
- **Target enrollment:** 954 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847912, "CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00847912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*